{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:50:03Z","timestamp":1787237403277,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.dsx.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:54:32Z","timestamp":1517482472000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Relationship of Polycystic Ovarian Syndrome with Cardiovascular Risk Factors"],"prefix":"10.1016","volume":"12","author":[{"given":"Muhammad","family":"Bilal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2018.01.006_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.dsx.2018.01.006_bib0010","first-page":"232","article-title":"Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women","volume":"2","author":"Alexander","year":"2009","journal-title":"Rev Obstetrics Gynecol"},{"issue":"August (191)","key":"10.1016\/j.dsx.2018.01.006_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejogrb.2015.05.005","article-title":"Oxidative stress and cardiovascular complications in polycystic ovarian syndrome","volume":"31","author":"Hyderali","year":"2015","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"issue":"June (3)","key":"10.1016\/j.dsx.2018.01.006_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"issue":"July (1)","key":"10.1016\/j.dsx.2018.01.006_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0015-0282(03)00571-5","article-title":"Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease","volume":"80","author":"Fenkci","year":"2003","journal-title":"Fertil Steril"},{"issue":"February (4)","key":"10.1016\/j.dsx.2018.01.006_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"February (2)","key":"10.1016\/j.dsx.2018.01.006_bib0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"May (3)","key":"10.1016\/j.dsx.2018.01.006_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1474651413495571","article-title":"Screening for diabetes and cardiometabolic disease in women with polycystic ovary syndrome","volume":"13","author":"Tomlinson","year":"2013","journal-title":"Br J Diabetes Vasc Dis"},{"issue":"January (1)","key":"10.1016\/j.dsx.2018.01.006_bib0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/09513590903159565","article-title":"Association of polycystic ovary syndrome with cardiovascular risk factors","volume":"26","author":"Akram","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"November (11)","key":"10.1016\/j.dsx.2018.01.006_bib0050","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.01.006_bib0055","first-page":"1","article-title":"(Obesity: preventing and managing the global epidemic. Report of a WHO consultation., 2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"November (11)","key":"10.1016\/j.dsx.2018.01.006_bib0060","first-page":"3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classifications of diabetes mellitus","volume":"26","author":"Kahn","year":"2003","journal-title":"Diabetes Care"},{"issue":"June (6)","key":"10.1016\/j.dsx.2018.01.006_bib0065","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"June (1)","key":"10.1016\/j.dsx.2018.01.006_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"issue":"Febuary (2)","key":"10.1016\/j.dsx.2018.01.006_bib0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"Van Hooff","year":"2004","journal-title":"Hum Reprod"},{"issue":"Febuary (1)","key":"10.1016\/j.dsx.2018.01.006_bib0080","first-page":"55","article-title":"Cardiometabolic aspects of polycystic ovarian syndrome","volume":"3","author":"Cho","year":"2007","journal-title":"Vasc Health Risk Manage"},{"issue":"April (2)","key":"10.1016\/j.dsx.2018.01.006_bib0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"issue":"July (2)","key":"10.1016\/j.dsx.2018.01.006_bib0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.fertnstert.2009.03.037","article-title":"Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome","volume":"94","author":"Adali","year":"2010","journal-title":"Fertil Steril"},{"issue":"January (1)","key":"10.1016\/j.dsx.2018.01.006_bib0095","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"Am J Med"},{"issue":"May (5)","key":"10.1016\/j.dsx.2018.01.006_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.dsx.2018.01.006_bib0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"issue":"March (3)","key":"10.1016\/j.dsx.2018.01.006_bib0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol"},{"issue":"March (3)","key":"10.1016\/j.dsx.2018.01.006_bib0115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"August (3)","key":"10.1016\/j.dsx.2018.01.006_bib0120","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.fertnstert.2009.04.008","article-title":"The insulin-resistant phenotype of polycystic ovary syndrome","volume":"94","author":"Svendsen","year":"2010","journal-title":"Fertil Steril"},{"issue":"Janaury (1)","key":"10.1016\/j.dsx.2018.01.006_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/07435800.2014.920350","article-title":"Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome","volume":"40","author":"Kuppusamy","year":"2015","journal-title":"Endocr Res"},{"issue":"June (6)","key":"10.1016\/j.dsx.2018.01.006_bib0130","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"Febuary (2)","key":"10.1016\/j.dsx.2018.01.006_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/01443615.2010.539722","article-title":"Insulin resistance and the long-term consequences of polycystic ovary syndrome","volume":"31","author":"Bhathena","year":"2011","journal-title":"J Obstet Gynaecol"},{"issue":"January (1)","key":"10.1016\/j.dsx.2018.01.006_bib0140","first-page":"22","article-title":"Endocrine correlates of polycystic ovary syndrome in Pakistani women","volume":"25","author":"Akram","year":"2015","journal-title":"J Coll Phys Surg Pak"},{"key":"10.1016\/j.dsx.2018.01.006_bib0145","series-title":"International association for the study of obesity, international obesity task force. The Asia-Pacific perspective: redefining obesity and its treatment","first-page":"15","author":"World Health Organization","year":"2000"},{"issue":"December (8)","key":"10.1016\/j.dsx.2018.01.006_bib0150","first-page":"599","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"ActaobstetriciaetgynecologicaScandinavica"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117304885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117304885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T10:00:36Z","timestamp":1535104836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117304885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1871402117304885"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.01.006","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of Polycystic Ovarian Syndrome with Cardiovascular Risk Factors","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}